Centralized Manufacturing– tag –
-
Decentralizing CAR-T Manufacturing: Point-of-Care Production to Slash Turnaround Times and Expand Therapeutic Access
Frontiers in Immunology Switzerland Overview CAR-T cell therapy, reliant on centralized manufacturing, is resource-intensive, time-consuming, and vulnerable to logistical disruptions. Interest in decentralized or point-of-care (POC) manu... -
Point-of-Care Cell Therapy Manufacturing Surges Forward with Miltenyi Biotec’s CliniMACS Prodigy and Octane Medical’s Cocoon Systems
BioPharm International USA Overview Miltenyi Biotec's CliniMACS Prodigy and Octane Medical Group's Cocoon systems are emerging as pivotal technologies for accelerating point-of-care (PoC) manufacturing in cell therapy. These modular, clo... -
BioProcess International Advocates for Building a Distributed Model for Future Autologous Cell Therapy Manufacturing
BioProcess International Netherlands Overview BioProcess International and IB Communications held a video roundtable proposing the construction of a distributed manufacturing model for the future of autologous cell therapy biomanufacturi... -
BioProcess International Advocates for Distributed Hybrid Model in Autologous Cell Therapy Manufacturing
BioProcess International USA Overview A BioProcess International video roundtable discussed the future of distributed biomanufacturing for autologous cell therapies. With centralized manufacturing struggling to scale and point-of-care mo...
1